Prostate cancer's genetic mutations will be mapped under a new $20 million Canadian research project that aims to eventually improve diagnosis and treatment of the disease.
The Canadian Prostate Cancer Genome Network will identify changes in the DNA sequences of prostate cancer.
The project is part of the International Cancer Genome Consortium, which is also looking at more than 10,000 tumours in the blood, brain, breast, colon, kidney, liver, lung, pancreas, stomach, oral cavity and ovaries.
Read more: http://www.cbc.ca/health/story...